Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today announced the start of the Company's first human clinical evaluation of ReGenica for hair regrowth. ReGenica is the first naturally stabilized and bioactive formulation of wnt proteins and natural cofactors, which are thought to act in the formation of new hair follicles. (PRWeb Nov 20, 2008)

Read the full story at http://www.prweb.com/releases/Histogen/HairStudy/prweb1643564.htm

Chairman of the Children's Hospital Foundation Board recognized at National Capital Philanthropy Day Awards (PRWeb Nov 20, 2008)

Read the full story at http://www.prweb.com/releases/2008/11/prweb1644124.htm

Stem cell culture innovator asks the regenerative medicine community: "Are Your Cells Free?" Learn more about InVitria at TERMIS North America 2008, Dec. 7-10 in San Diego, CA. (PRWeb Nov 19, 2008)

Read the full story at http://www.prweb.com/releases/TERMIS/BEFREE/prweb1637864.htm

Trusted LASIK Surgeons launched its revolutionary Trusted LASIK S'urgeons directory service and website at www.TrustedLASIKSurgeons.com in order to provide a resource for consumers seeking to improve their vision. What sets the Trusted LASIK Surgeons directory apart is a unique screening process ensuring that only those who are among the best in LASIK Eye Surgery, Laser Surgeons in the United States are listed. Refractive eye surgeons, such as Dr. Michael Raizman, are screened based on their experience, research, publications, lectures and patient care standards. Trusted LASIK Surgeons believes Doctor Raizmans experience, research, teaching, and other professional accomplishments place him among the top 1% of LASIK surgeons in the United States. Dr. Raizman's refractive practice at Ophthalmic Consultants of Boston serves the greater Boston area with offices in Boston and Waltham. (PRWeb Nov 19, 2008)

Read the full story at http://www.prweb.com/releases/boston-lasik-eye-surgery/dr-michael-raizman/prweb1591844.htm

In a report unprecedented in the healthcare industry, Zannos Grekos, MD presented clinical data this week to the Dubai Congress on Regenerative Biomedical Technologies demonstrating the successful treatment of end-stage heart disease and vascular disease using Autologous Adult Stem Cell Therapy. Dr. Grekos offered cardiac nuclear scans, PET scans, and echocardiographs performed at six months and one year post-treatment, which confirm the regeneration of damaged heart tissue, the existence of new blood vessels and a dramatic improvement in heart function in patients treated with adult stem cells extracted from their own blood. (PRWeb Nov 19, 2008)

Read the full story at http://www.prweb.com/releases/stem_cell/adult_stem/prweb1643054.htm

Finding of No Cardiovascular Protection Was Predictable (PRWeb Nov 18, 2008)

Read the full story at http://www.prweb.com/releases/2008/11/prweb1635644.htm

M2S Inc., an industry leader in endovascular treatment planning and patient registries, announced today that the company has reached a new milestone, having processed over 150,000 radiographic scans for evaluation and surveillance of aortic aneurysms. With each scan received, M2S evaluates approximately 1,000 images, pushing M2S' total images received and processed to over 150 million. (PRWeb Nov 18, 2008)

Read the full story at http://www.prweb.com/releases/endovascular/imaging/prweb1631214.htm

A new study published in the New England Journal of Medicine lends further importance to the screening of C-reactive protein (CRP) in the detection of heart disease and stroke risk. Life Line Screening provides CRP screening along with glucose and cholesterol screenings. (PRWeb Nov 17, 2008)

Read the full story at http://www.prweb.com/releases/CRP-study/CRP-screening/prweb1618124.htm

Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that its partner, Tripep AB, reported positive additional interim results from its ongoing phase I/II clinical study of its therapeutic DNA vaccine against hepatitis C virus (HCV). This vaccine is being delivered using Inovio’s electroporation-based DNA delivery system. In the third and highest dose cohort of the study, two of three subjects demonstrated reductions in viral load of 93% and 99.7%. Previously reported middle dose cohort results demonstrated an 87% and 98% reduction in HCV in two of three subjects, while no anti-viral effect was observed in the low dose cohort. No safety issues have been noted to date in the trial. These data suggest a potential dose response of the vaccine and support the inclusion of three additional subjects in the high dose cohort. (PRWeb Nov 17, 2008)

Read the full story at http://www.prweb.com/releases/dna_vaccine/inovio_biomedical/prweb1627194.htm

Blair Keagy, MD, CEO, is pleased to announce the launch of MPAnalytics, Inc. - a medical consultant group dedicated to helping businesses evaluate the commercial potential of new medical products and technologies. (PRWeb Nov 17, 2008)

Read the full story at http://www.prweb.com/releases/medical_consultant/blair_keagy/prweb1627584.htm

T-Gone Tinnitus Remedies today published the results of what could very well be be the most significant tinnitus survey since the 1980's.The survey, which was completed by over 1,700 tinnitus patients, was aimed at discovering the exact tinnitus noises and sounds experienced by thousands of tinnitus patients. The severity of the noises was also explored. (PRWeb Nov 16, 2008)

Read the full story at http://www.prweb.com/releases/tinnitus/survey/prweb1618184.htm

Scientists at The Feinstein Institute for Medical Research have figured out why a substance in red grapes and red wine lowers amyloid beta levels that accumulate in the brains of Alzheimer’s patients. (PRWeb Nov 16, 2008)

Read the full story at http://www.prweb.com/releases/Feinstein_Institute/Alzheimers_red_wine/prweb1617724.htm

Life Quest Anatomical, an Allentown, Pa. based whole body donor program offers free cremation to those who donate their bodies to support medical science. (PRWeb Nov 16, 2008)

Read the full story at http://www.prweb.com/releases/2008/11/prweb1618324.htm

Biotrial, a leading CRO for early phase clinical trials, today announced that Monique Duguépéroux-Klocke has joined the company as its new Head of Data Management. (PRWeb Nov 15, 2008)

Read the full story at http://www.prweb.com/releases/2008/11/prweb1612544.htm

Biotrial, a leading CRO for early phase clinical trials, today announced a new executive appointment of Didier Chassard, MD, as Associate Medical and Scientific Director (PRWeb Nov 15, 2008)

Read the full story at http://www.prweb.com/releases/2008/11/prweb1612574.htm

It's one of the most debilitating diseases known to man, and new findings about Alzheimer's disease have just been posted on the Natural Health News Report website. To read the entire report about the latest in these cutting edge research results, visit http://www.naturalhealthnewsreport.com/rept/report0005.pdf?x=webb0201 (PRWeb Nov 14, 2008)

Read the full story at http://www.prweb.com/releases/2008/11/prweb1609614.htm

At the recent American Academy of Ophthalmology (AAO) annual meeting in Atlanta, many top honors were awarded to members of the Trusted LASIK Surgeons Directory for their extensive contributions to refractive surgery procedures, including LASIK eye surgery. Dr. Roger Steinert received the Barraquer Award, Dr. Douglas Koch was the Guest of Honor of the AAO meeting, Dr. Jack Holladay was honored with a Founder's Award, and Dr. Ronald Kreuger received with the Lans Distinguished Award. In addition, LASIK surgeons James Salz, Stephen Brint, Marguerite McDonald, and Richard Duffery received awards recognizing their achievements in refractive surgery research. (PRWeb Nov 14, 2008)

Read the full story at http://www.prweb.com/releases/2008/11/prweb1591824.htm

Molecular Medicine, a bimonthly, biomedical journal published by The Feinstein Institute for Medical Research, strives to understand normal body functioning and disease pathogenesis at the molecular level which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. Featured in the November/December issue: “Chronic Lymphocytic Leukemia Cells Recognize Conserved Epitopes Associated with Apoptosis and Oxidation”, “Angiogenesis and Diabetes: Different Responses to Pro-Angiogenic Factors in the Chorioallantoic Membrane Assay”, and “Estradiol’s Salutary Effects on Keratinocytes following Trauma-Hemorrhage Are Mediated by Estrogen Receptor (ER)-α and ER-β”. (PRWeb Nov 14, 2008)

Read the full story at http://www.prweb.com/releases/2008/11/prweb1613334.htm

Through the "Sichuan Post-disaster Reconstruction Support and Research Centre", PolyU and Sichuan University have not only provided timely post-quake relief and reconstruction services for the victims, but also offered training for more than 3,000 relief workers and volunteers using the "Training-the-Trainers" approach. (PRWeb Nov 14, 2008)

Read the full story at http://www.prweb.com/releases/2008/11/prweb1611044.htm

The Aerobics and Fitness Association of America and the Swezey Institute of Santa Monica create at-home exercise training that promotes bone and joint health. (PRWeb Nov 13, 2008)

Read the full story at http://www.prweb.com/releases/2008/11/prweb1605414.htm